NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma.
Neri L, Lasa M, Elosegui-Artola A, D'Avola D, Carte B, Gazquez C, Alve S, Roca-Cusachs P, Iñarrairaegui M, Herrero J, Prieto J, Sangro B, Aldabe R.
Neri L, et al.
Oncotarget. 2017 Jun 20;8(25):40967-40981. doi: 10.18632/oncotarget.17332.
Oncotarget. 2017.
PMID: 28498797
Free PMC article.